Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags Read more
Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare Read more
Enveda reaps $311M series E to feed ambition to become a ‘household name’ Read more
February 4, 2025 @ 11:30 am

Presentations from the Olink team on the value of combining genomic and proteomic data for the best insights into human disease and development of new therapeutics, and more. After, enjoy lunch and networking.